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L. Iselin, M. Naef, H.E. Wagner and W.G. Mouton*Department of Surgery, Spital Thun-Simmental AG, Thun, SwitzerlandObjective. To assess the success of peripheral venous access for implantation of venous access device in large series of
patients with the aim of avoiding central venous puncture with its potential complications and costs.
Design. Retrospective cohort study.
Methods. During a 4-year period (January 2001–December 2004), 302 consecutive patients underwent implantation of a
venous access device. The first choice was peripheral venous access. If this failed the subclavian vein was punctured for
access.
Results. Access was gained via the cephalic vein in 246 patients (81%), in eight patients via other peripheral veins (3%) and
the subclavian vein was punctured in 48 patients (16%). Pneumothorax occurred in two patients who underwent subclavian
vein puncture (0.7% of all and 4% of patients with subclavian vein puncture) and was managed by insertion of a chest drain.
There were no other perioperative complications. The average cost was 680 Euros for implantation via a peripheral vein and
993 Euros when the subclavian vein was used for access. Mean operating time for all 302 procedures was 36 min.
Conclusions. Peripheral venous access was possible in 84% of our patients and may be the access of first choice for
implantation of venous access device to avoid central venous puncture with its potential morbidity, rare mortality and
additional costs.Keywords: Venous access; Implantation; Venous access device; Pneumothorax.Introduction
Central venous access devices are used in patients
needing repeated central venous access for adminis-
tration of cytotoxic and other drugs and to obtain
blood samples for analysis. The venous access device
can be placed peripherally or in a central vein. Central
venous puncture has its morbidity (mainly pneu-
mothorax) and a very low mortality. Peripheral access
is not always possible.
Our aim was to assess the success rate of peripheral
venous access in order to avoid central venous
puncture and its complications and costs.Material and Methods
Three hundred and two consecutive unselecteding author. Wolfgang G. Mouton, MS, MD, PhD,
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device during a 4-year period (1st January 2001–31st
December 2004).
The study population comprised 150 female
patients and 152 men. The age of the patients ranged
from 21 to 73 years (mean 64.5 years). In 98% of the
patients the underlying disease was malignant and
chemotherapy was required. The procedure was
performed under local anaesthesia (280 patients or
93%) unless another procedure was performed at the
same time (22 patients or 7%) demanding general
anaesthesia. Single shot antibiotic prophylaxis was
given as a routine (cefuroxime). The infraclavicular
incision was either transverse or in the deltoideo-
pectoral sulcus depending on the surgeon’s prefer-
ence. As a first choice the cephalic vein was chosen for
catheter insertion. As a second choice thoraco-acro-
mial vein branches or muscular vein branches were
used for insertion. If there was no peripheral vein for
access then the subclavian vein was punctured and the
catheter was inserted with an introducer set. Implan-
tation was done in a standard manner according to theEJVES Extra 10, 54–56 (2005)
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Implantable Venous Access Device 55instruction for the use of PORT-A-CATH (SIMS Deltec
Inc., St Paul, MN, USA). For the correct placement of
the catheter an image intensifier was used. Subcu-
taneous tissue and skin was closed in two layers. No
vacuum wound drain was inserted. Whenever the
subclavian vein was punctured a postoperative chest
X-ray was performed. The all-inclusive price for an
ambulatory PORT-A-CATH (PAC)-implantation was
680 Euro. Additional costs include introducer sets
costs (47 Euro per set), additional chest X-rays (50 Euro
each), insertion of chest drain (406 Euro all-inclusive),
and 630 Euro per hospitalisation day. Follow-up
management was by the oncologists in all patients.Results
In 246 patients (81%) the cephalic vein could be used
for PAC-implantation. In eight cases (3%) other
peripheral veins were usable; in two cases thoraco-
acromial branches and in six cases deltoideal and
pectoral muscular venous branches. In 48 cases (16%)
the subclavian vein had to be punctured for access.
From these 48 punctures pneumothorax resulted on
two occasions (0.7% of all and 4% of patients with
subclavian vein puncture). These two patients were
managed by insertion of a chest drain. In the first
patient it was possible to remove the chest drain only
after 6 days, the second patient suffered from chronic
obstructive airway disease and the chest drain had to
be maintained for 9 days due to a prolonged air leak.
There were no other peri-operative complications.
There was no peri-operative mortality.
The average costs per patient was 680 Euro for
implantation via a peripheral vein. Average costing
per patient was 993 Euro when the subclavian vein
was used for access, according to the costs as defined
in methods section.
In the first month after the operation there was no
other complication in addition to the cases of
pneumothorax. There was no case of infection,
thrombosis or catheter dislocation.
Mean operating time for all 302 procedures was
36 min. The mean operating time in the peripheral
vein group was 33 min and in the subclavian vein
group 50 min.Discussion
The infraclavicular venous PAC can be implanted via
peripheral veins, mainly the cephalic vein but also via
thoraco-acromial, basilic and muscular vein branchesor left persistent superior vena cava. Central venous
access can be done via the subclavian and jugular vein.
Other routes of access are also possible, for example
via the long saphenous vein. Some centres prefer
peripheral access, some use mainly or purely the
subclavian vein.1–6
A prospective randomised trial comparing implan-
tation of PAC via cephalic versus subclavian vein
showed no significant differences concerning associ-
ated morbidity, technical failure, operating time and
patient acceptance in a total of 50 patients.3
However, incidence of pneumothorax goes up to
4.7% when subclavian vein is punctured.6 Severe and
lethal complications resulting from subclavian vein
puncture exist including pseudoaneurysm, perfor-
ation into neighbouring structures and air embo-
lism.7–9
In our series, pneumothorax occurred only when
the subclavian vein was punctured. In 84% of patients
implantation was possible via peripheral access. Mean
operating time, with that peripheral implantation
success rate of 84%, was only 36 min. Costs were
higher when the subclavian vein was punctured due
to additional equipment, X-rays, complications and
hospitalisation time.
We, therefore, conclude that peripheral access is
possible in the majority of patients. Morbidity,
mortality and costs resulting from subclavian vein
puncture can be avoided using peripheral access. We
recommend peripheral access as first choice for
implantation of peripheral venous access device.References
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